Highlighting Clinical Pearls in Dermatology Through the Eyes of a Rheumatologist
This session at the DERM 2025 conference highlights several clinical pearls in dermatology and was presented by rheumatologist Karim Ladak, MD.
Related Articles
Infectious Disease Screening in Substance Use Treatment Programs Effective, Study Finds
Co-locating ID screening in an inpatient SUD program resulted in timely identification of and linkage to care for viral hepatitis and latent tuberculosis.
Implications of Findings on Roflumilast Cream 0.05% for Atopic Dermatitis, with Adelaide Hebert, MD
This segment of Hebert’s DERM 2025 interview highlights additional conclusions from her team’s data on roflumilast in atopic dermatitis among infants and toddlers.
EYP-1901 Implant Extends Duration of Wet AMD Treatment, with Avni Finn, MD, MBA
The new, bioerodible intravitreal implant, which periodically releases the tyrose kinase inhibitor vorolanib, may be capable of reducing treatment burden for at least 6 months.
ATTAIN-1: Orforglipron Achieves Up to 12% Weight Loss in Phase 3 Obesity Trial
The once-daily oral GLP-1 RA met the primary endpoint for body weight reduction at 72 weeks and demonstrated improvements in cardiovascular risk factors.
Top 5 Posters from DERM 2025 NP/PA Conference
In this list of the top 5 posters featured at the DERM 2025 conference, a variety of recent data are spotlighted in alopecia areata, atopic…
Oral Berotralstat Shows Strong Safety, Efficacy in Young Children with HAE
In this large study, oral berotralstat resulted in early and sustained reductions in HAE attack rates, offering a promising long-term prophylaxis option.
Top 5 Posters from DERM 2025 NP/PA Conference
In this list of the top 5 posters featured at the DERM 2025 conference, a variety of recent data are spotlighted in alopecia areata, atopic…
Automated Skin Prick Test at 4.5 mm Cut-Off Matches Accuracy of Traditional Method
A 4.5 mm cut-off using the Skin Prick Automated Test showed comparable accuracy to the standard skin prick test in detecting birch pollen and house…
Intravitreal UBX1325 Shows Efficacy in Diabetic Retinopathy, DME, with Dante Pieramici, MD
Results from the BEHOLD and ASPIRE trials indicate the long lasting effects of UBX1325 in improving retinal function and structure.
Reducing Steroid Burden in gMG With CD19 Targeting, with Richard Nowak, MD, MS
Nowak also shared his outlook on research in myasthenia gravis in the next 5 years.